Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) Study

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty Opinions recommendation of Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1122755.579832 ◽

2008 ◽

Author(s):

Wolfgang Schoels

Keyword(s):

Coronary Artery Disease ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Double Blind Placebo ◽

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

The Lancet ◽

10.1016/s0140-6736(08)61170-8 ◽

2008 ◽

Vol 372 (9641) ◽

pp. 807-816 ◽

Cited By ~ 694

Author(s):

Kim Fox ◽

Ian Ford ◽

P Gabriel Steg ◽

Michal Tendera ◽

Roberto Ferrari

Keyword(s):

Coronary Artery Disease ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Double Blind Placebo ◽

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

Yearbook of Cardiology ◽

10.1016/s0145-4145(09)79536-x ◽

2009 ◽

Vol 2009 ◽

pp. 279-282

Author(s):

B.J. Gersh

Keyword(s):

Coronary Artery Disease ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Double Blind Placebo ◽

Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial

Heart ◽

10.1136/heart.88.4.373 ◽

2002 ◽

Vol 88 (4) ◽

pp. 373-377 ◽

Cited By ~ 67

Author(s):

S D Hutcheon

Keyword(s):

Older Patients ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Walking Distance ◽

Double Blind ◽

Double Blind Placebo

Faculty Opinions recommendation of Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120774.597955 ◽

2009 ◽

Author(s):

Brian Olshansky

Keyword(s):

Coronary Artery Disease ◽

Heart Rate ◽

Risk Factor ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Artery Disease ◽

Randomised Controlled

Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction: Insights from the VA CART Program

American Heart Journal ◽

10.1016/j.ahj.2021.02.002 ◽

2021 ◽

Author(s):

Todd J. Brophy ◽

Theodore J. Warsavage ◽

Annika L. Hebbe ◽

Mary E. Plomondon ◽

Stephen W. Waldo ◽

...

Keyword(s):

Coronary Artery Disease ◽

Percutaneous Coronary Intervention ◽

Systolic Dysfunction ◽

Coronary Intervention ◽

Left Ventricular ◽

Percutaneous Coronary ◽

055 The INDYCE Survey. Prevalence of left ventricular systolic dysfunction in stable coronary artery disease patients: Systolic ventricular function assessment is necessary in stable CAD patients

Archives of Cardiovascular Diseases Supplements ◽

10.1016/s1878-6480(10)70057-4 ◽

2010 ◽

Vol 2 (1) ◽

pp. 18

Author(s):

Marie Christine Malergue ◽

Maxime Guenoun ◽

Franck Paganelli ◽

Patrick Jourdain ◽

Yves Alamercery ◽

...

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Artery Disease ◽

Stable Cad ◽

Function Assessment

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(08)61171-x ◽

2008 ◽

Vol 372 (9641) ◽

pp. 817-821 ◽

Cited By ~ 523

Author(s):

Kim Fox ◽

Ian Ford ◽

P Gabriel Steg ◽

Michal Tendera ◽

Michele Robertson ◽

...

Keyword(s):

Coronary Artery Disease ◽

Heart Rate ◽

Risk Factor ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Artery Disease ◽

Randomised Controlled

Faculty Opinions recommendation of Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120774.577023 ◽

2008 ◽

Author(s):

Chim Lang

Keyword(s):

Coronary Artery Disease ◽

Heart Rate ◽

Risk Factor ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Artery Disease ◽

Randomised Controlled

Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study

http://isrctn.org/> ◽

10.1186/isrctn70429960 ◽

2012 ◽

Author(s):

Karl Swedberg

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Multicentre Study ◽

Cardiovascular Events ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Double Blind Placebo